Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples